UTAH MEDICAL PRODUCTS, INC. Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax
UTAH MEDICAL PRODUCTS, INC. (UTMD) had Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax of $0 as of 2018-12-31, per its 10-K filed 2019-03-14.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax · last filed 2019-03-14
- 2018-12-31: Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax $0.00.
- 2017-12-31: Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax $0.00.
| Period end | Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax |
|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-14 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |